Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46
NCT04410809
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
TA-46
OTHER:
Placebo
Sponsor
Pfizer